NOVA MENTIS BIOTECH
NOVA is a research and development driven company that is focused on investigating the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes. NOVA is of the view that its target indications represent vast and growing segments of the population.
NOVA MENTIS BIOTECH
Industry:
Biotechnology Cannabis Health Care Therapeutics
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Total Employee:
1+
Status:
Active
Similar Organizations
Imagen Biotech
Imagen Biotech is focused on identifying and developing therapeutics for blinding diseases.
Symmetry Therapeutics, Inc.
Creating the world’s most robust mitochondrial carrier drug platform to treat common and rare metabolic diseases.
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-09 | Pilz Bioscience | Pilz Bioscience acquired by Nova Mentis Biotech | N/A |
More informations about "Nova Mentis Biotech"
Nova Mentis Pharma – Reaching new heights for more patients.
Nova Mentis Pharma is a company dedicated to the search for “New Beginnings” and providing high quality solutions towards unmet medical needs. Our focused strategy is to develop …See details»
Nova Mentis Life Sciences Corporation - Psychedelic Science Review
Nova Mentis Life Sciences Corporation Vancouver, Canada-based biotechnology company Nova Mentis Life Sciences was founded by Dr. Aylia Mohammadi in 2004. William Rascan became …See details»
Nova Mentis Expands Psilocybin Research Program Targets …
Sep 7, 2021 Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in developing diagnostics and psilocybin-based therapeutics for …See details»
Nova Mentis Receives Health Canada Approval for First-Of-Its …
Dec 22, 2022 Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in developing diagnostics and psilocybin-based therapeutics for …See details»
About Us - Nova Mentis
Nova Mentis (CSE: NOVA) is a pioneering Canadian life sciences company committed to addressing today's health challenges with transformative solutions. As innovators and market …See details»
Nova Mentis Granted Health Canada Section 56 Exemption to …
Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. …See details»
Nova Mentis Assigns Intellectual Property - BioSpace
Aug 27, 2024 Nova Mentis Life Science Corp. is a Canadian-based biotechnology company, developing psilocybin-based therapeutics for neuroinflammatory disorders. Nova is the first …See details»
Nova Mentis Applauds Government Decision to Create Rare …
Nov 3, 2023 Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in developing diagnostics and psilocybin-based therapeutics for …See details»
Nova Mentis Life Science Company Profile - Office Locations ...
Oct 10, 2024 Nova Mentis Life Science is a biotechnology company that provides psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. It …See details»
Nova Mentis Life Science Corp | Psychedelic Invest
Nova Mentis Life Science Corp. (formerly Liberty Leaf Holdings Ltd.) is a Canadian-based, public company whose focus is to build and support a diversified portfolio of health and wellness businesses. Key holdings include …See details»
Nova Mentis Receives Health Canada Approval for First-of-its-Kind ...
The human study will evaluate the Company’s proprietary psilocybin drug (NM-1001) in the treatment of Fragile X Syndrome Vancouver, British Columbia – December 22, 2022 – Nova …See details»
Nova Mentis Biotech - Products, Competitors, Financials, …
About Nova Mentis Biotech NOVA is a research and development driven company that is focused on investigating the anti-inflammatory effects of psilocybin in underexplored metabolic …See details»
Liberty Leaf to Acquire Nova Mentis Biotech Corp. - Newswire
Jun 22, 2020 Liberty Leaf to Acquire Nova Mentis Biotech Corp. - Liberty Leaf Augments Portfolio with Entrance into the Emerging Psilocybin Therapy Market News provided by Liberty …See details»
Nova Mentis Provides Corporate Update - 2022 Planned Catalysts
Jan 12, 2022 Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in developing diagnostics and psilocybin-based therapeutics for …See details»
U.S. FDA Approves Nova Mentis Orphan Drug Application
Nov 2, 2021 Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in developing diagnostics and psilocybin-based therapeutics for …See details»
Investors - Nova Mentis
Nova Mentis (CSE: NOVA) is a pioneering Canadian life sciences company committed to addressing today's health challenges with transformative solutions. As innovators and market …See details»
Nova Mentis Assigns Intellectual Property - The Globe and Mail
Aug 27, 2024 About Nova Mentis Life Science Corp. Nova Mentis Life Science Corp. is a Canadian-based biotechnology company, developing psilocybin-based therapeutics for …See details»
Nova Mentis Life Science Completes Acquisition of Pilz Bioscience
Nov 30, 2020 Nova Mentis Life Science Corp. (formerly Liberty Leaf Holdings Ltd.) is a Canadian-based, public company whose focus is to build and support a diversified portfolio of …See details»
Nova Mentis Completes Production of Psilocybin Microdose …
Sep 15, 2022 Nova Mentis Life Science Corp., a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for …See details»
Nova Mentis Announces Share Consolidation and Name Change
Oct 31, 2024 Nova Mentis Life Sciences Corp. is set to undergo a share consolidation, reducing its outstanding shares from 148 million to approximately 30 million, and plans a name change …See details»